hyperlipidemia

And what they did here was they introduced a five-stage system, so stages zero through stage four, to help providers figure out where a patient sits and how aggressive to be with their treatment, with stage four being a patient with established cardiovascular disease layered on top of the pre-existing metabolic and kidney disease risk factors.

Another thing to note is that they're also pushing the newer PREVENT risk equations, which we discussed with the Hyperlipidemia podcast.

As a reminder, these bake kidney function and metabolic factors directly into the cardiovascular risk estimate.

management of hypertension and hyperlipidemia.